SCYNEXIS, Inc. Public Float
SCYNEXIS, Inc. (SCYX) had Public Float of $25.65 million as of 2025-06-30, per its 10-K filed 2026-03-04.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-03-04
- 2025-06-30: Entity Public Float $25.65M.
- 2024-06-28: Entity Public Float $74.95T.
- 2023-06-30: Entity Public Float $109.14T.
- 2022-06-30: Entity Public Float $60.15M.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $25.65M 10-K · filed 2026-03-04 |
| 2024-06-28 | $74.95T 10-K · filed 2025-03-12 |
| 2023-06-30 | $109.14T 10-K · filed 2024-03-28 |
| 2022-06-30 | $60.15M 10-K · filed 2023-03-31 |
| 2021-06-30 | $168.97M 10-K/A · filed 2022-05-02 |
| 2020-06-30 | $77.94M 10-K · filed 2021-03-29 |
| 2019-06-28 | $70.46M 10-K · filed 2020-03-11 |
| 2018-06-30 | $75.73M 10-K · filed 2019-03-14 |
| 2017-06-30 | $46.52B 10-K · filed 2018-03-13 |
| 2016-06-30 | $50.06M 10-K · filed 2017-03-13 |
| 2015-06-30 | $95.91M 10-K · filed 2016-03-07 |
| 2014-06-30 | $27.04M 10-K · filed 2015-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| VERU INC. (VERU) | United States | $0.043B | -3.93 |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |